Author:
Jabbour Elias,Garcia-Manero Guillermo,Cortes Jorge,Ravandi Farhad,Plunkett William,Gandhi Varsha,Faderl Stefan,O'Brien Susan,Borthakur Gautam,Kadia Tapan,Burger Jan,Konopleva Marina,Brandt Mark,Huang Xuelin,Kantarjian Hagop
Funder
National Cancer Institute, Department of Health and Human Services
Subject
Cancer Research,Oncology,Hematology
Reference20 articles.
1. How I treat older patients with AML;Estey;Blood,2000
2. Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy;Gandhi;J Clin Oncol,1993
3. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia;Gandhi;Clin Cancer Res,1995
4. Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy;Gandhi;Clin Cancer Res,1997
5. Variables predicting response to high dose cytosine arabinoside therapy in patients with refractory acute leukemia;Estey;Leucemia,1987
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献